Man W, Wang S, Yang H. Exploring the spatial-temporal distribution and evolution of population aging and social-economic indicators in China. BMC Public Health. 2021;21(1):966.

Article  PubMed  PubMed Central  Google Scholar 

Arita T, Suzuki S, Yagi N, et al. Association between number of medications and mortality among older adult patients in a specialized cardiology hospital. Geriatr Gerontol Int. 2021;21(11):985.

Article  PubMed  Google Scholar 

Guillot J, Maumus-Robert S, Bezin J. Polypharmacy: a general review of definitions, descriptions and determinants. Therapie. 2020;75(5):407.

Article  PubMed  Google Scholar 

Yao S-S, Cao G-Y, Han L et al. Prevalence and patterns of Multimorbidity in a nationally Representative Sample of older Chinese: results from the China Health and Retirement Longitudinal Study. The journals of gerontology Series A, Biological sciences and medical sciences. 2020;75(10):1974.

Morin L, Johnell K, Laroche M-L, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289.

Article  PubMed  PubMed Central  Google Scholar 

Slater N, White S, Venables R, Frisher M. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA). BMJ open. 2018;8(3):e020270.

Article  PubMed  PubMed Central  Google Scholar 

Wang R, Chen L, Fan L, et al. Incidence and effects of Polypharmacy on Clinical Outcome among patients aged 80+: a five-year Follow-Up study. PLoS ONE. 2015;10(11):e0142123.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X-M, Jiao J, Guo N, Bo H-X, Xu T, Wu X-J. Association of polypharmacy with falls among older Chinese inpatients: a nationwide cohort study. Geriatr Gerontol Int. 2021;21(9):810.

Article  PubMed  Google Scholar 

Onder G, Marengoni A, Polypharmacy. JAMA. 2017;318(17):1728.

Article  PubMed  Google Scholar 

Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181.

Article  PubMed  Google Scholar 

Ballesteros SM, Moreno-Montoya J, Grooten WJA, Barrera-López P. Hoz-Valle JADl. Socioeconomic variation of multimorbidity in Colombian older adults. Sci Rep. 2021;11(1):22738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carmona-Torres JM, Cobo-Cuenca AI, Recio-Andrade B, Laredo-Aguilera JA, Martins MM, Rodríguez-Borrego MA. Prevalence and factors associated with polypharmacy in the older people: 2006–2014. J Clin Nurs. 2018;27(15–16):2942.

Article  PubMed  Google Scholar 

Parker K, Wong J. Is polypharmacy an increasing burden in chronic kidney disease? The German experience. Clin Kidney J. 2019;12(5):659.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Yang C, Jiang J, Hu Y, Hao Y, Dong J-Y. Polypharmacy, chronic kidney disease, and mortality among older adults: a prospective study of National Health and nutrition examination survey, 1999–2018. Frontiers in public health. 2023;11:1116583.

Min HK, Sung SA, Chung W, et al. Polypharmacy and the progression of chronic kidney disease: Korean cohort study for Outcome in patients with chronic kidney disease. Kidney Blood Press Res. 2021;46(4):460.

Article  CAS  PubMed  Google Scholar 

Villén N, Guisado-Clavero M, Fernández-Bertolín S, et al. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study. BMC Geriatr. 2020;20(1):206.

Article  PubMed  PubMed Central  Google Scholar 

Kostev K, Jacob L. Multimorbidity and polypharmacy among elderly people followed in general practices in Germany. Eur J Intern Med. 2018;55:66.

Article  PubMed  Google Scholar 

Ernst R, Fischer K, Molino CGRC, et al. Polypharmacy and kidney function in Community-Dwelling adults Age 60 years and older: a prospective observational study. J Am Med Dir Assoc. 2020;21(2):254.

Article  PubMed  Google Scholar 

Kimura H, Tanaka K, Saito H, et al. Association of Polypharmacy with kidney disease progression in adults with CKD. Clin J Am Soc Nephrology: CJASN. 2021;16(12):1797.

Article  CAS  Google Scholar 

Whitney DG, Schmidt M, Haapala H. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy. J Managed care Specialty Pharm. 2021;27(1):51.

Article  Google Scholar 

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME. Kidney function, polypharmacy, and potentially inappropriate medication use in a community-based cohort of older adults. Drugs Aging. 2018;35(8):735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. Mortality and global health estimates: causes of death; projections for 2015–2039; projection of death rates. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates.

Wang X, Liu K, Shirai K, et al. Prevalence and trends of polypharmacy in U.S. adults, 1999–2018. Global Health Res Policy. 2023;8(1):25.

Article  Google Scholar 

Yang M, Lu J, Hao Q, Luo L, Dong B. Does residing in urban or rural areas affect the incidence of polypharmacy among older adults in western China? Arch Gerontol Geriatr. 2015;60(2):328.

Article  PubMed  Google Scholar 

Cheng C, Bai J. Association between Polypharmacy, anxiety, and Depression among Chinese older adults: evidence from the Chinese longitudinal healthy longevity survey. Clin Interv Aging. 2022;17:235.

Article  PubMed  PubMed Central  Google Scholar 

Sakamoto J-I, Shikata T, Ito S, et al. Polypharmacy is Associated with accelerated deterioration of renal function in Cardiovascular outpatients. Cardiol Res. 2020;11(1):15.

Article  PubMed  PubMed Central  Google Scholar 

Wakasugi M, Yokoseki A, Wada M, et al. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study. J Bone Miner Metab. 2022;40(1):157.

Article  PubMed  Google Scholar 

König M, Gollasch M, Demuth I, Steinhagen-Thiessen E. Prevalence of impaired kidney function in the German Elderly: results from the Berlin Aging Study II (BASE-II). Gerontology. 2017;63(3):201.

Article  PubMed  Google Scholar 

Lu L, Yao K, Chen J, et al. Prevalence of potentially inappropriate medications and association with comorbidities in older adults with diabetes in an outpatient visitation setting. Front Public Health. 2022;10:995948.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura T, Itoh T, Yabe A, et al. Polypharmacy is associated with malnutrition and activities of daily living disability among daycare facility users: a cross-sectional study. Med (Baltim). 2021;100(34):e27073.

Article  Google Scholar 

Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443.

Article  PubMed  PubMed Central  Google Scholar 

Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ open. 2016;6(3):e010989.

Article  PubMed  PubMed Central  Google Scholar 

Barbieri MA, Rottura M, Cicala G et al. Chronic kidney Disease Management in General Practice: a focus on inappropriate drugs prescriptions. J Clin Med. 2020;9(5).

Docherty M-H, O’Sullivan ED, Bonventre JV, Ferenbach DA. Cellular Senescence in the kidney. J Am Soc Nephrology: JASN. 2019;30(5):726.

Article  CAS  PubMed Central  Google Scholar 

Robinson P. Pharmacology, polypharmacy and the older adult: a review. Br J Community Nurs. 2021;26(6):290.

Article  PubMed  Google Scholar 

Kim J, Parish AL. Polypharmacy and Medication Management in older adults. Nurs Clin N Am. 2017;52(3):457.

Article  Google Scholar 

Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19.

Article  PubMed  PubMed Central  Google Scholar 

Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug Register. Drug Saf. 2007;30(10):911.

Article  PubMed  Google Scholar 

Scondotto G, Pojero F, Addario SP, et al. The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy. Aging Clin Exp Res. 2018;30(1):81.

Article  PubMed  Google Scholar 

Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67.

Article  CAS  PubMed  Google Scholar 

Okoro RN, Farate VT. The use of nephrotoxic drugs in patients with chronic kidney disease. Int J Clin Pharm. 2019;41(3):767.

Article  CAS  PubMed  Google Scholar 

Chang F, O’Hare AM, Miao Y, Steinman MA. Use of Renally Inappropriate medications in older veterans: a National Study. J Am Geriatr Soc. 2015;63(11):2290.

Article